Kenneth Bader to Fibrinolytic Agents
This is a "connection" page, showing publications Kenneth Bader has written about Fibrinolytic Agents.
Connection Strength
3.253
-
(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy. PLoS One. 2022; 17(1):e0261567.
Score: 0.689
-
Design and Characterization of an Ultrasound Transducer for Combined Histotripsy-Thrombolytic Therapy. IEEE Trans Ultrason Ferroelectr Freq Control. 2022 01; 69(1):156-165.
Score: 0.689
-
In Vitro Thrombolytic Efficacy of Single- and Five-Cycle Histotripsy Pulses and rt-PA. Ultrasound Med Biol. 2020 02; 46(2):336-349.
Score: 0.596
-
Efficacy of histotripsy combined with rt-PA in vitro. Phys Med Biol. 2016 07 21; 61(14):5253-74.
Score: 0.470
-
Sonothrombolysis. Adv Exp Med Biol. 2016; 880:339-62.
Score: 0.455
-
Assessment of bubble activity generated by histotripsy combined with echogenic liposomes. Phys Med Biol. 2022 Oct 31; 67(21).
Score: 0.182
-
Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi. Sci Rep. 2021 11 23; 11(1):22805.
Score: 0.171